![]() |
同义名 : | - |
CAS号 : | 1802326-66-4 | |
货号 : | A159562 | |
分子式 : | C17H17ClN2O2 | |
纯度 : | 99%+ | |
分子量 : | 316.78 | |
MDL号 : | MFCD29924732 | |
存储条件: |
Pure form Sealed in dry, room temperature In solvent -20°C:3-6个月-80°C:12个月 |
|
溶解度 : | - | |
动物实验配方: |
生物活性 | |||
---|---|---|---|
描述 | GPR139 is an orphan G-protein–coupled receptor enriched in the Habenula and Septum. JNJ-63533054 is a potent, selective, small-molecule GPR139 agonist. It activated human GPR139 in the calcium mobilization and GTPgS binding assays with EC50 values of 16±6 and 17±4nM, respectively. JNJ-63533054 also activated rat and mouse GPR139 receptors with EC50 values of 63±24 and 28±7nM, respectively. The inhibition equilibrium constants (Ki) of JNJ-63533054 for binding to the membrane of cells expressing human, rat or mouse GPR139 are 23±3, 75±25, 54±12nM, respectively. L-Trp and L-Phe competed for [3H]JNJ-63533054 binding sites in T-REx CHO cells expressing human GPR139 with Ki values of 738±64 and 872±7μM, respectively. In Sprague-Dawley rats, JNJ-63533054 at dosages of 3, 10, and 30mg/kg induced a dose-dependent reduction in locomotor activity in the first hour after the treatment when compared with the vehicle-treated group[3]. | ||
作用机制 | JNJ-63533054 is a potent agonist of GPR139, an orphan G protein-coupled receptor expressed in the central nervous system[3]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.16mL 0.63mL 0.32mL |
15.78mL 3.16mL 1.58mL |
31.57mL 6.31mL 3.16mL |
参考文献 |
---|